InDex Pharmaceuticals Holding AB (1NP1) Revenue

5 Followers

InDex Pharmaceuticals Holding AB Revenue

InDex Pharmaceuticals Holding AB had a revenue of -800.00K in the quarter ending Jun 30, 2026, with 89.61%. This bring the company's revenue in the last twelve months to -21.00M, Decreased 13.22%. In the fiscal year ending Dec 31, 2025, InDex Pharmaceuticals Holding AB had annual revenue of 8.80M with 8700.00% growth.

Revenue (ttm)

-21.00M

Revenue Growth

-198.18%

P/S Ratio

16.00

Revenue/Employee

€4,400,000

Employees

Market Cap

€140.76M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	8.80M	8.70M	+8,700.00%
Dec 31, 2024	100.00K	-97.41M	-99.90%
Dec 31, 2023	97.50M	―	+∞%
Dec 31, 2022	―	―	―
Dec 31, 2021	―	-35.00K	-100.00%
Dec 31, 2020	35.00K	-53.00K	-60.23%
Dec 31, 2019	88.00K	-40.00K	-31.25%
Dec 31, 2018	128.00K	15.00K	+13.27%
Dec 31, 2017	113.00K	―	―